+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Movember 2026: what should men know about prostate cancer, testicular cancer, and mental health?

16 Nov 2026
1 minutes
Movember 2026: what should men know about prostate cancer, testicular cancer, and mental health?

Movember is an annual men's health campaign that runs every November, and in 2026 it continues to focus on three causes: prostate cancer, testicular cancer, and men's mental health and suicide prevention. Participants grow mustaches, get active, host events, or raise funds to start conversations that many men tend to postpone. In the United States, men live about five fewer years than women on average, according to federal health statistics, and each of Movember's causes carries a measurable burden.

This article explains what Movember is, what each of its three causes involves, which warning signs and screening decisions matter, and how clinical research has changed outcomes for men.

What is Movember, and why the mustache?

Movember is a blend of "mustache" and "November." The campaign began in 2003 in Melbourne, Australia, when a small group of friends agreed to grow mustaches for the month and turned the idea into a fundraiser for men's health. The charity that grew out of that effort now runs the campaign in many countries and reports funding more than a thousand men's health projects worldwide.

The mustache works as a conversation starter. A visible change on a man's face prompts questions from coworkers, friends, and family, and those questions open the door to topics such as cancer screening and mental health that rarely come up on their own.

The 2026 campaign, "Make a Growmitment," asks participants to commit to the cause alongside a friend, whether by growing a mustache, taking on a physical activity challenge, hosting an event, or fundraising. The money raised supports work in three focus areas:

  • Prostate cancer
  • Testicular cancer
  • Mental health and suicide prevention

Movember complements Men's Health Month in June, which looks at men's health more broadly, including why men's participation in clinical trials matters. November is narrower by design: three causes, one month, and a direct ask to act.

Prostate cancer: when should men talk about screening?

The prostate is a walnut-sized gland that sits below the bladder and helps produce semen. Other than skin cancer, prostate cancer is the most common cancer in American men, and about 1 in 8 men will be diagnosed with it during their lifetime, according to a national cancer organization.

Two trends define the current picture. The prostate cancer death rate has fallen by about half since the early 1990s, a decline attributed to earlier detection and better treatment. At the same time, new diagnoses have been rising in recent years, and advanced-stage diagnoses have been rising faster than early-stage ones.

What is a PSA test?

A PSA (prostate-specific antigen) test is a blood test that measures a protein made by the prostate. PSA is an example of a biomarker, a measurable signal from the body. A high PSA level can point to cancer, but it can also reflect an enlarged prostate, inflammation, or other noncancerous conditions.

This is the difference between screening and diagnosis. Screening looks for possible signs of disease in people without symptoms. Diagnosis confirms whether disease is actually present, usually through imaging and a biopsy (removal of a small tissue sample for examination).

What does shared decision-making mean for prostate screening?

The federal preventive services panel recommends that men ages 55 to 69 make an individual decision about PSA screening after discussing the potential benefits and harms with a clinician. This process is called shared decision-making. Screening may modestly lower the chance of dying from prostate cancer, but it can also lead to false-positive results, biopsy complications, and overdiagnosis (finding slow-growing cancers that would never have caused harm), which can result in treatment side effects such as urinary or sexual problems.

The panel recommends against routine PSA screening for men 70 and older. Its current recommendation dates to 2018, and an update is in progress. A national cancer organization suggests starting the conversation at 50 for men at average risk, at 45 for men at higher risk, and at 40 for men at very high risk, such as those with more than one close relative diagnosed at an early age.

Risk is not evenly distributed. Black men are diagnosed with prostate cancer at a markedly higher rate than White men and die from it at about twice the rate. Yet Black men have made up only a small fraction of participants in trials for advanced prostate cancer, far below their share of people living with the disease. That gap reflects system-level barriers to access, and it limits how much is known about how treatments work for the men most affected.

Testicular cancer: who is at risk, and what are the signs?

The testicles (testes) are the two egg-shaped glands inside the scrotum that produce sperm and testosterone. Testicular cancer is uncommon, with a lifetime risk of about 1 in 250, but unlike most cancers it mainly affects young and middle-aged men. The average age at diagnosis is in the early thirties.

It is also one of the most treatable cancers. More than nine in ten men diagnosed with testicular cancer are alive five years later, and outcomes are generally best when it is found before it spreads.

What are the common signs of testicular cancer?

Most testicular cancers are found because a man notices a change. Signs to report to a healthcare provider include:

  • A lump in either testicle, painful or painless
  • Swelling or enlargement of a testicle
  • A feeling of heaviness in the scrotum
  • A dull ache in the lower abdomen or groin

These symptoms often have noncancerous causes, but they warrant prompt evaluation rather than a wait-and-see approach. A testicular self-exam is a brief check, often done during or after a warm shower, in which a man gently rolls each testicle between his fingers to learn what is normal for him.

A national cancer organization does not recommend routine self-exams for every man, because research has not shown that they reduce deaths. It does advise seeing a doctor right away about any lump, and men with risk factors such as an undescended testicle, a previous testicular cancer, or a family history may want to discuss regular self-exams with their doctor.

The high survival rate is a direct product of clinical trials. Before the mid-1970s, testicular cancer that had spread beyond the testicle was rarely curable. Trials of platinum-based combination chemotherapy beginning in that decade made most of these cancers curable, and later trials refined treatment to reduce side effects. Testicular cancer is not the only cancer men may not expect, and breast cancer in men follows a similar pattern of late recognition and limited research.

Men's mental health and suicide: why does the gap persist?

Suicide is where the difference between men and women is widest. Federal health statistics show that in 2024, men died by suicide at nearly four times the rate of women, and the highest rate was among men 75 and older.

Men are also less likely to receive mental health care. In the 2024 national survey on drug use and mental health, fewer than half of men with a mental illness received treatment, compared with roughly six in ten women.

How can depression look different in men?

The federal mental health research institute notes that men with depression may show anger, irritability, or aggressiveness rather than sadness, and may report physical symptoms such as fatigue, headaches, or digestive problems. Signs that warrant a conversation with a healthcare provider or mental health professional include:

  • Persistent irritability, anger, or restlessness
  • Withdrawal from friends, family, or usual activities
  • Changes in sleep or energy
  • Increased alcohol or drug use
  • Risk-taking behavior

Structured questionnaires used in primary care can help identify depression that might otherwise be mistaken for stress. Readers can learn more about how depression screening works and what happens after a positive result.

Where to get help now

Anyone thinking about suicide, or worried about someone else, can call or text 988 or use the online chat to reach the 988 Suicide and Crisis Lifeline. The service is free and available 24 hours a day. Veterans can dial 988 and then press 1 to reach responders trained to support veterans. If someone is in immediate danger, call 911.

How does clinical research move men's health forward?

A clinical trial is a research study in which volunteers help test whether a new test, treatment, or prevention approach is safe and effective. Every Movember cause depends on this process. In prostate cancer, trials supported newer imaging that targets a protein called PSMA and can find small cancer deposits that standard scans miss, as well as targeted radioactive medicines for some men with advanced disease.

Research also established active surveillance (close monitoring with regular tests instead of immediate treatment) as an option for low-risk prostate cancer. In one large U.S. registry of urology practices, its use among men with low-risk disease rose from about one in four in 2014 to about six in ten by 2021, sparing many men treatment side effects they did not need.

Representation remains a gap. In randomized trials of talk therapy and behavioral treatments for depression, men made up only about a quarter of participants, according to a 2023 review of more than one hundred studies. When men, especially men from higher-risk groups, are missing from studies, researchers have less evidence about how well treatments work for them.

Taking part in research is voluntary, and not everyone qualifies. Each study has eligibility criteria, and the research team explains the study's purpose, procedures, risks, and the right to leave at any time before anyone joins. Knowing how to read an informed consent form helps people ask the right questions. Research participation is not a substitute for crisis care or for ongoing treatment from a regular healthcare provider.

Frequently asked questions about Movember

When is Movember 2026?

Movember runs for the full month of November, from Sunday, November 1, through Monday, November 30, 2026. Participants traditionally start clean-shaven on November 1 and grow a mustache through the month.

How is Movember different from Men's Health Month and International Men's Day?

Men's Health Month takes place in June and covers men's health broadly. International Men's Day falls on November 19 (a Thursday in 2026) and focuses on the wellbeing and contributions of men and boys. Movember centers on three specific causes and funds projects in those areas.

Can people without a mustache take part?

Yes. Anyone can join by taking on an activity challenge, hosting an event, or fundraising. Growing a mustache is one option, not a requirement.

Turning Movember awareness into action

Awareness matters most when it leads to a specific step: a conversation about PSA screening, a prompt appointment for any testicular change, or reaching out about mental health. Clinical research is one more way to contribute.

DecenTrialz is a clinical trial recruitment and participant management platform that helps connect people with relevant clinical studies through AI matching, nurse-led pre-screening, and structured referral workflows. People share some information, get matched with studies that may fit, and a registered nurse reviews their information before any referral to a research site team. DecenTrialz does not provide medical care, and it does not guarantee eligibility, enrollment, or any health outcome.

The research site team makes all decisions about eligibility, informed consent, and enrollment.


Was this article helpful?

Paramraj
Written and Reviewed by :
Paramraj

Share

Stay Informed. Stay Connected.

Get updates on verified clinical trials, emerging treatments, and research breakthroughs directly in your inbox. No spam, just science that matters.